HUP0103832A3 - Triazolopyridines for the treatment of thrombosis disorders, pharmaceutical compositions containing the same and process for preparation thereof - Google Patents
Triazolopyridines for the treatment of thrombosis disorders, pharmaceutical compositions containing the same and process for preparation thereofInfo
- Publication number
- HUP0103832A3 HUP0103832A3 HU0103832A HUP0103832A HUP0103832A3 HU P0103832 A3 HUP0103832 A3 HU P0103832A3 HU 0103832 A HU0103832 A HU 0103832A HU P0103832 A HUP0103832 A HU P0103832A HU P0103832 A3 HUP0103832 A3 HU P0103832A3
- Authority
- HU
- Hungary
- Prior art keywords
- triazolopyridines
- preparation
- treatment
- pharmaceutical compositions
- same
- Prior art date
Links
- 208000007536 Thrombosis Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000008523 triazolopyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9423198P | 1998-07-27 | 1998-07-27 | |
| PCT/US1999/016572 WO2000006570A1 (en) | 1998-07-27 | 1999-07-21 | Triazolopyridines for the treatment of thrombosis disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0103832A2 HUP0103832A2 (hu) | 2002-04-29 |
| HUP0103832A3 true HUP0103832A3 (en) | 2002-12-28 |
Family
ID=22243910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0103832A HUP0103832A3 (en) | 1998-07-27 | 1999-07-21 | Triazolopyridines for the treatment of thrombosis disorders, pharmaceutical compositions containing the same and process for preparation thereof |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6303625B1 (hu) |
| EP (1) | EP1102766B1 (hu) |
| JP (1) | JP2003527306A (hu) |
| KR (1) | KR20010079576A (hu) |
| CN (1) | CN1320125A (hu) |
| AR (1) | AR019477A1 (hu) |
| AT (1) | ATE263169T1 (hu) |
| AU (1) | AU757512B2 (hu) |
| BR (1) | BR9912556A (hu) |
| CA (1) | CA2338654A1 (hu) |
| CZ (1) | CZ2001347A3 (hu) |
| DE (1) | DE69916073T2 (hu) |
| ES (1) | ES2219042T3 (hu) |
| HU (1) | HUP0103832A3 (hu) |
| ID (1) | ID27214A (hu) |
| MX (1) | MXPA01001099A (hu) |
| NO (1) | NO20010456L (hu) |
| PL (1) | PL345769A1 (hu) |
| SK (1) | SK1342001A3 (hu) |
| WO (1) | WO2000006570A1 (hu) |
| ZA (1) | ZA200100783B (hu) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306909B1 (en) | 1997-03-12 | 2001-10-23 | Queen's University At Kingston | Anti-epileptogenic agents |
| PT1265606E (pt) * | 1999-08-13 | 2007-01-31 | Biogen Idec Inc | Inibidores da adesão celular |
| TWI288745B (en) | 2000-04-05 | 2007-10-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| EP1397136A1 (en) * | 2001-05-25 | 2004-03-17 | Queen's University At Kingston | Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents |
| WO2003000657A1 (en) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Diamine derivatives |
| BRPI0514391A (pt) * | 2004-08-18 | 2008-06-10 | Pharmacia & Upjohn Co Llc | compostos de triazolopiridina para o tratamento de inflamação |
| US7618983B2 (en) * | 2004-11-10 | 2009-11-17 | Janssen Pharmaceutica, N.V. | Bicyclic triazole α4 integrin inhibitors |
| BRPI0615775B1 (pt) * | 2005-09-16 | 2021-08-10 | Daiichi Sankyo Company, Limited | Processos para a produção de compostos derivados de diamida oticamente ativos |
| CA2665195C (en) * | 2006-10-11 | 2011-08-09 | Amgen Inc. | Imidazo- and triazolo-pyridine compounds and methods of use thereof |
| EP2417135A1 (en) * | 2009-04-07 | 2012-02-15 | Schering Corporation | Substituted triazolopyridines and analogs thereof |
| US8871760B2 (en) * | 2009-09-21 | 2014-10-28 | Roche Palo Alto Llc | [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators |
| EP2755976B1 (en) | 2011-09-15 | 2018-07-18 | Novartis AG | 6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyridines as c-met tyrosine kinase inhibitors |
| CN105408331A (zh) * | 2013-06-03 | 2016-03-16 | 拜耳制药股份公司 | 作为用于治疗血栓栓塞病症的凝血酶抑制剂的三唑并吡啶 |
| GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3050525A (en) | 1960-12-14 | 1962-08-21 | John B Bicking | Certain derivatives of s-triazolo [4, 3-a]-pyridine |
| WO1994018981A1 (en) | 1993-02-22 | 1994-09-01 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| DE4326758A1 (de) * | 1993-08-10 | 1995-02-16 | Basf Ag | [1,3,4]Triazolo[1,5-a]pyridine |
| CA2134192A1 (en) | 1993-11-12 | 1995-05-13 | Michael L. Denney | 5, 6-bicyclic glycoprotein iib/iiia antagonists |
-
1999
- 1999-07-15 US US09/354,032 patent/US6303625B1/en not_active Expired - Lifetime
- 1999-07-21 CZ CZ2001347A patent/CZ2001347A3/cs unknown
- 1999-07-21 BR BR9912556-0A patent/BR9912556A/pt not_active Application Discontinuation
- 1999-07-21 JP JP2000562372A patent/JP2003527306A/ja active Pending
- 1999-07-21 AU AU52218/99A patent/AU757512B2/en not_active Ceased
- 1999-07-21 HU HU0103832A patent/HUP0103832A3/hu unknown
- 1999-07-21 CN CN99811380A patent/CN1320125A/zh active Pending
- 1999-07-21 SK SK134-2001A patent/SK1342001A3/sk unknown
- 1999-07-21 PL PL99345769A patent/PL345769A1/xx not_active Application Discontinuation
- 1999-07-21 KR KR1020017001183A patent/KR20010079576A/ko not_active Withdrawn
- 1999-07-21 ES ES99937373T patent/ES2219042T3/es not_active Expired - Lifetime
- 1999-07-21 AT AT99937373T patent/ATE263169T1/de not_active IP Right Cessation
- 1999-07-21 CA CA002338654A patent/CA2338654A1/en not_active Abandoned
- 1999-07-21 ID IDW20010365A patent/ID27214A/id unknown
- 1999-07-21 DE DE69916073T patent/DE69916073T2/de not_active Expired - Fee Related
- 1999-07-21 EP EP99937373A patent/EP1102766B1/en not_active Expired - Lifetime
- 1999-07-21 MX MXPA01001099A patent/MXPA01001099A/es unknown
- 1999-07-21 WO PCT/US1999/016572 patent/WO2000006570A1/en not_active Ceased
- 1999-07-26 AR ARP990103671A patent/AR019477A1/es unknown
-
2001
- 2001-01-26 NO NO20010456A patent/NO20010456L/no not_active Application Discontinuation
- 2001-01-26 ZA ZA200100783A patent/ZA200100783B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000006570A1 (en) | 2000-02-10 |
| PL345769A1 (en) | 2002-01-02 |
| KR20010079576A (ko) | 2001-08-22 |
| AR019477A1 (es) | 2002-02-20 |
| CZ2001347A3 (cs) | 2001-12-12 |
| DE69916073T2 (de) | 2004-12-30 |
| HUP0103832A2 (hu) | 2002-04-29 |
| EP1102766A1 (en) | 2001-05-30 |
| CA2338654A1 (en) | 2000-02-10 |
| ID27214A (id) | 2001-03-08 |
| NO20010456D0 (no) | 2001-01-26 |
| EP1102766B1 (en) | 2004-03-31 |
| BR9912556A (pt) | 2002-01-15 |
| JP2003527306A (ja) | 2003-09-16 |
| ATE263169T1 (de) | 2004-04-15 |
| ZA200100783B (en) | 2002-01-28 |
| MXPA01001099A (es) | 2002-04-24 |
| CN1320125A (zh) | 2001-10-31 |
| SK1342001A3 (en) | 2002-04-04 |
| US6303625B1 (en) | 2001-10-16 |
| NO20010456L (no) | 2001-03-26 |
| AU757512B2 (en) | 2003-02-20 |
| AU5221899A (en) | 2000-02-21 |
| ES2219042T3 (es) | 2004-11-16 |
| DE69916073D1 (de) | 2004-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL125735A0 (en) | Pharmaceutical compositions for the treatment of glaucoma | |
| HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
| HUP9701096A3 (en) | Use of benzenesulfonamides for the preparation of pharmaceutical compositions treating disorders of the central nervous system, novel derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0102556A3 (en) | Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds | |
| HUP0001607A3 (en) | Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds | |
| HUP0301167A3 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP9603495A2 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation | |
| IL127798A (en) | N-substituted indol-3-glyoxylamides, process for their preparation and pharmaceutical compositions comprising them | |
| HUP9900974A3 (en) | Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
| HUP0204399A3 (en) | Pteridine compounds for the treatment of psoriasis, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP9701193A3 (en) | Use of n-(4-aryl-thiazol-2-yl)-sulfonamide derivatives for the preparation of pharmaceutical compositions treating neurological disorders, new derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0104762A3 (en) | Pharmaceutical moxifloxacin compositions and process for their preparation | |
| HUP0000426A3 (en) | Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation | |
| IL139658A0 (en) | Pharmaceutical compositions for treatment and prophylaxis and method for their preparation | |
| HUP0200284A3 (en) | 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders, process for their preparation and pharmaceutical compositions containing them | |
| IL112895A (en) | Pharmaceutical compositions for the treatment of obsessive-compulsive disorders comprising 5-HT2 antagonists | |
| HUP0102512A3 (en) | Bridged indenopyrrolocarbazoles, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0102215A3 (en) | Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation | |
| GB2311940B (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| HUP0201402A3 (en) | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them | |
| HUP0103832A3 (en) | Triazolopyridines for the treatment of thrombosis disorders, pharmaceutical compositions containing the same and process for preparation thereof | |
| HUP0003577A3 (en) | Tetrahydro gamma-carbolines, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP0001093A3 (en) | Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation | |
| HUP9601680A3 (en) | Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds | |
| HUP0104202A3 (en) | Thiazole-derivatives, process for their preparation and pharmaceutical compositions containing them |